Andrew  Dudum net worth and biography

Andrew Dudum Biography and Net Worth

Co-Founder, Chairman & CEO of Hims & Hers Health
Andrew is a Founder & CEO at Hims & Hers. He is also a Cofounder and General Partner at Atomic, a venture-builder in San Francisco backed by Peter Thiel, Marc Andreessen and many of the leading venture funds in the world.

He is serial founder, active angel investor and advisor to over two dozen startups. Andrew graduated from the WhartonSchool of the University of Pennsylvania with a bachelor's degree in Management and Economics.

What is Andrew Dudum's net worth?

The estimated net worth of Andrew Dudum is at least $3.82 million as of September 17th, 2025. Mr. Dudum owns 95,315 shares of Hims & Hers Health stock worth more than $3,816,413 as of December 4th. This net worth evaluation does not reflect any other investments that Mr. Dudum may own. Additionally, Mr. Dudum receives a salary of $1,980,000.00 as Co-Founder, Chairman & CEO at Hims & Hers Health. Learn More about Andrew Dudum's net worth.

How old is Andrew Dudum?

Mr. Dudum is currently 35 years old. There are 6 older executives and no younger executives at Hims & Hers Health. Learn More on Andrew Dudum's age.

What is Andrew Dudum's salary?

As the Co-Founder, Chairman & CEO of Hims & Hers Health, Inc., Mr. Dudum earns $1,980,000.00 per year. Learn More on Andrew Dudum's salary.

How do I contact Andrew Dudum?

The corporate mailing address for Mr. Dudum and other Hims & Hers Health executives is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. Hims & Hers Health can also be reached via phone at 415-851-0195 and via email at [email protected]. Learn More on Andrew Dudum's contact information.

Has Andrew Dudum been buying or selling shares of Hims & Hers Health?

Andrew Dudum has not been actively trading shares of Hims & Hers Health over the course of the past ninety days. Most recently, Andrew Dudum sold 65,110 shares of the business's stock in a transaction on Wednesday, September 17th. The shares were sold at an average price of $50.57, for a transaction totalling $3,292,612.70. Following the completion of the sale, the chief executive officer now directly owns 95,315 shares of the company's stock, valued at $4,820,079.55. Learn More on Andrew Dudum's trading history.

Who are Hims & Hers Health's active insiders?

Hims & Hers Health's insider roster includes Jack Abraham (Major Shareholder), Melissa Baird (COO), Irene Becklund (Insider), Irene Becklund (Insider), Soleil Boughton (Insider), Patrick Carroll (Insider), Michael Chi (Chief Commercial Officer), Andrew Dudum (Co-Founder, Chairman & CEO), Spencer Lee (CFO), Anja Manuel (Director), Oluyemi Okupe (CFO), Christopher Payne (Director), and David Wells (Director). Learn More on Hims & Hers Health's active insiders.

Are insiders buying or selling shares of Hims & Hers Health?

In the last year, insiders at the sold shares 94 times. They sold a total of 3,695,388 shares worth more than $166,986,368.93. The most recent insider tranaction occured on November, 17th when CFO Oluyemi Okupe sold 23,187 shares worth more than $853,513.47. Insiders at Hims & Hers Health own 13.7% of the company. Learn More about insider trades at Hims & Hers Health.

Information on this page was last updated on 11/17/2025.

Andrew Dudum Insider Trading History at Hims & Hers Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/17/2025Sell65,110$50.57$3,292,612.7095,315View SEC Filing Icon  
9/16/2025Sell128,127$53.48$6,852,231.96160,425View SEC Filing Icon  
9/16/2025Sell47,534$53.27$2,532,136.1895,058View SEC Filing Icon  
8/18/2025Sell128,127$45.06$5,773,402.6289,521View SEC Filing Icon  
8/7/2025Sell660,000$50.58$33,382,800.002,214,769View SEC Filing Icon  
7/21/2025Sell125,335$49.54$6,209,095.9092,313View SEC Filing Icon  
7/16/2025Sell2,792$50.58$141,219.3692,313View SEC Filing Icon  
7/16/2025Sell47,534$50.25$2,388,583.50190,126View SEC Filing Icon  
6/17/2025Sell65,110$59.22$3,855,814.2095,105View SEC Filing Icon  
6/16/2025Sell128,127$56.76$7,272,488.52160,215View SEC Filing Icon  
6/16/2025Sell47,534$56.51$2,686,146.34237,660View SEC Filing Icon  
5/16/2025Sell128,127$58.40$7,482,616.8089,311View SEC Filing Icon  
5/16/2025Sell47,534$58.25$2,768,855.50285,194View SEC Filing Icon  
4/29/2025Sell50,000$36.39$1,819,500.0092,103View SEC Filing Icon  
4/16/2025Sell36,460$28.04$1,022,338.4092,103View SEC Filing Icon  
3/17/2025Sell128,127$33.98$4,353,755.46173,655View SEC Filing Icon  
2/18/2025Sell128,127$58.27$7,465,960.2997,687View SEC Filing Icon  
1/31/2025Sell100,000$35.22$3,522,000.0027,918View SEC Filing Icon  
1/23/2025Sell27,098$30.08$815,107.8427,918View SEC Filing Icon  
1/21/2025Sell300$30.00$9,000.0027,918View SEC Filing Icon  
1/16/2025Sell36,460$27.09$987,701.4027,918View SEC Filing Icon  
12/16/2024Sell78,127$29.62$2,314,121.74109,956View SEC Filing Icon  
12/2/2024Sell33,513$33.38$1,118,663.9433,502View SEC Filing Icon  
11/5/2024Sell188,888$20.88$3,943,981.4467,015View SEC Filing Icon  
9/20/2024Sell45,767$16.33$747,375.1167,015View SEC Filing Icon  
9/3/2024Sell188,888$14.56$2,750,209.2833,502View SEC Filing Icon  
8/5/2024Sell188,888$16.47$3,110,985.3633,502View SEC Filing Icon  
7/3/2024Sell188,888$20.75$3,919,426.0033,502View SEC Filing Icon  
6/20/2024Sell45,755$22.97$1,050,992.3533,502View SEC Filing Icon  
6/4/2024Sell188,888$19.88$3,755,093.44View SEC Filing Icon  
5/1/2024Sell188,888$12.54$2,368,655.52View SEC Filing Icon  
4/4/2024Sell188,888$14.97$2,827,653.36View SEC Filing Icon  
3/20/2024Sell50,361$16.34$822,898.74View SEC Filing Icon  
2/13/2024Sell97,208$9.58$931,252.6451,653View SEC Filing Icon  
1/29/2024Sell15,100$9.01$136,051.0051,653View SEC Filing Icon  
1/25/2024Sell127,688$9.08$1,159,407.0451,653View SEC Filing Icon  
12/29/2023Sell21,432$9.06$194,173.9251,653View SEC Filing Icon  
12/27/2023Sell7,700$9.02$69,454.0051,653View SEC Filing Icon  
12/1/2023Sell24,300$9.03$219,429.00View SEC Filing Icon  
8/8/2023Sell6,900$9.04$62,376.00View SEC Filing Icon  
7/19/2023Sell23,800$9.06$215,628.00View SEC Filing Icon  
6/29/2023Sell23,282$9.02$210,003.64View SEC Filing Icon  
6/6/2023Sell71,933$9.13$656,748.29385,947View SEC Filing Icon  
6/2/2023Sell2,009$9.04$18,161.36357,938View SEC Filing Icon  
1/20/2022Buy1,500$5.17$7,755.00View SEC Filing Icon  
12/13/2021Buy81,100$5.93$480,923.00View SEC Filing Icon  
6/18/2021Sell22,142$12.07$267,253.94364,339View SEC Filing Icon  
5/24/2021Sell196,553$10.56$2,075,599.68View SEC Filing Icon  
See Full Table

Andrew Dudum Buying and Selling Activity at Hims & Hers Health

This chart shows Andrew Dudum's buying and selling at Hims & Hers Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hims & Hers Health Company Overview

Hims & Hers Health logo
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Read More

Today's Range

Now: $40.04
Low: $37.72
High: $40.46

50 Day Range

MA: $46.14
Low: $33.64
High: $62.79

2 Week Range

Now: $40.04
Low: $23.97
High: $72.98

Volume

24,652,590 shs

Average Volume

21,227,630 shs

Market Capitalization

$9.12 billion

P/E Ratio

74.15

Dividend Yield

N/A

Beta

2.41